Abbott Laboratories and a unit of Reckitt Benckiser Group were cleared by a jury over claims they hid risks in their premature-infant formulas can cause a bowel disease that severely sickened a baby ...
In response, shares in Reckitt Benckiser soared 9.8% to 5,144.20 pence each in London early Friday. Reckitt was the best performing stock in the FTSE 100 index which was up 0.2%. Abbott Laboratories ...
A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...
The decision marks the first victory for the companies as they face more than 1,000 similar cases and previously lost trials, one of which ended with a $500 million verdict.
Préma-Québec says there is panic on a Facebook group that brings together thousands of parents who have premature babies. In particular, mothers are asking if other users could provide them with a ...